Walleye Capital
ARRY

Walleye Capital’s Array Biopharma Inc ARRY Stock Holding History

Walleye Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,700
Closed -$774K – 2452
2019
Q2 		$774K Buy
16,700
+15,300
+1,093% +$430K 0.09% 348
2019
Q1 		$34K Buy
+1,400
New +$29.1K 0.01% 1282

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Walleye Capital's ARRY Position: Q3 2019 in Review

Walleye Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,500 shares — an estimated $116K sold.

Walleye Capital first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $212K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Walleye Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Walleye Capital sold 2,500 Array Biopharma Inc shares in Q3 2019, an estimated $116K.
  • Walleye Capital first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • Walleye Capital's Array Biopharma Inc position peaked at $212K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.